Key facts
- NRx Pharmaceuticals priced a public offering of common stock.
- The offering raised $20 million.
- The stock was priced at $3.50 per share.
NRx Pharmaceuticals has priced a public offering of $20 million in common stock. The offering was priced at $3.50 per share. The offering is expected to close on or about June 14, 2024. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company. A public offering of common stock is when a company sells new shares of its stock to the public to raise capital. The pricing of the offering will determine the amount of capital NRx Pharmaceuticals raises and can affect its stock valuation.